Antigen Specific Induced T Regulatory Cellular Therapy for Graft-Versus-Host Disease Following Allogeneic Bone Marrow Transplantation
Allogeneic hematopoietic stem cell transplantation (allo-HCT) has been a successful cellular therapy for patients suffering from hematological malignancies for many decades; however, the beneficial effects of graft-versus-leukemia (GVL) are classically offset by graft-versus-host disease (GVHD). GVH...
Main Author: | Heinrichs, Jessica Lauren |
---|---|
Format: | Others |
Published: |
Scholar Commons
2016
|
Subjects: | |
Online Access: | http://scholarcommons.usf.edu/etd/6093 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=7289&context=etd |
Similar Items
-
H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect
by: Eun Young Choi, et al.
Published: (2020-06-01) -
Interleukin-22 in graft-versus-host disease after allogeneic stem cell transplantation
by: BAPTISTE eLAMARTHEE, et al.
Published: (2016-04-01) -
Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate
by: Jingjing Han, et al.
Published: (2017-11-01) -
Biomarkers in graft versus host disease after allogeneic hematopoietic stem cell transplant
by: Geary, Joshua J.
Published: (2016) -
IMMUNOBIOLOGY OF ACUTE GRAFT-VERSUS-HOST DISEASE
by: G. A. Efimov, et al.
Published: (2016-01-01)